Snapshot Shows Targeted Site Monitoring Trend

Has FDA Guidance on Risk-based Monitoring Impacted SDV Coverage Yet?

This Compendium consists of presentation materials submitted by speakers that complement their presentations from CBI’s Risk-Based Approaches to Clinical Investigations.  CBI has provided information and networking opportunities for thousands of executives in industries such as pharmaceuticals, biotech, medical devices and managed care.  We understand what an important resource this material is and we have made a concerted effort to secure biographical sketches, outlines and related materials from the conference. 

Otsuka Pharmaceutical Development & Commercialization, Inc. 

 Associate Director, Compliance Operations & Oversight, 

 Chief Science Officer & Clinical Director, 

News

The Risk-Based Approaches to Clinical Investigations compendia consists of conference presentation materials submitted by speakers and industry thought leaders